KYMERA THERAPEUTICS, INC. (KYMR) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$73.58M*; Operating income -$75.61M; Depreciation and amortization $2.03M*.
- 2026-03-31: Basis Reported; EBITDA -$82.13M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$95.86M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$90.37M*; Operating income -$92.52M; Depreciation and amortization $2.15M*.
Complete source-backed ebitda history.
- Available history
- 2019-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$73.58M* | -$75.61M | $2.03M* | $65.00M | -113.20%* | $473.00K* | -$54.06M* | (m) | $119.48M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$82.13M | (m) | (m) | (m) | -239.00% | $434.00K | -$88.84M | (m) | $98.16M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$95.86M | (m) | (m) | (m) | -3340.21% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$90.37M* | -$92.52M | $2.15M* | $2.76M | -3269.61%* | $181.00K* | -$27.11M* | (m) | $74.09M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$82.47M* | -$84.56M | $2.08M* | $11.48M | -718.66%* | $695.00K* | -$59.88M* | (m) | $78.39M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$72.38M | (m) | (m) | (m) | -327.50% | $467.00K | -$79.15M | (m) | $80.25M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$78.77M | (m) | (m) | (m) | -1065.30% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$70.14M* | -$72.12M | $1.99M* | $3.74M | -1874.82%* | -$189.00K* | -$50.19M* | (m) | $60.41M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$48.99M* | -$50.92M | $1.94M* | $25.65M | -190.98%* | $4.69M* | -$42.94M* | (m) | $59.20M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$56.37M | (m) | (m) | (m) | -547.97% | $7.40M | -$39.59M | (m) | $48.82M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$18.42M | (m) | (m) | (m) | -38.47% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$56.61M* | -$57.51M | $895.00K* | $4.73M | -1197.42%* | $8.08M* | -$31.65M* | (m) | $48.12M | (m) | $100.00K |
|---|
| 2023-06-30 | Reported | -$42.48M* | -$43.38M | $900.00K* | $16.51M | -257.27%* | $10.77M* | -$35.26M* | (m) | $45.77M | (m) | $100.00K |
|---|
| 2023-03-31 | Reported | -$44.45M | (m) | (m) | (m) | -469.54% | $4.01M | -$43.97M | (m) | $42.23M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$37.81M | (m) | (m) | (m) | -234.29% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$44.12M* | -$44.88M | $767.00K* | $9.55M | -461.89%* | $1.25M* | -$34.27M* | (m) | $43.88M | (m) | $0.00 |
|---|
| 2022-06-30 | Reported | -$40.10M* | -$40.81M | $705.00K* | $11.51M | -348.32%* | $735.00K* | -$38.98M* | (m) | $41.29M | (m) | $0.00 |
|---|
| 2022-03-31 | Reported | -$36.25M | (m) | (m) | (m) | -376.70% | $482.00K | -$40.30M | (m) | $35.94M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$33.31M | (m) | (m) | (m) | -218.04% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$27.97M* | -$28.64M | $671.00K* | $20.34M | -137.52%* | $306.00K* | -$37.26M* | (m) | $38.31M | (m) | $0.00 |
|---|
| 2021-06-30 | Reported | -$24.18M* | -$24.73M | $552.00K* | $18.52M | -130.56%* | $626.00K* | -$30.51M* | (m) | $35.22M | (m) | $0.00 |
|---|
| 2021-03-31 | Reported | -$12.68M | (m) | (m) | (m) | -67.82% | $164.00K | -$22.82M | (m) | $25.96M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$12.29M | (m) | (m) | (m) | -96.09% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$7.59M* | -$8.08M | $490.00K* | $14.53M | -52.25%* | $2.41M* | $131.67M* | (m) | $15.78M | (m) | $0.00 |
|---|
| 2020-06-30 | Reported | -$13.80M* | -$14.19M | $389.00K* | $3.29M | -419.80%* | $3.85M* | -$11.41M* | (m) | $13.82M | (m) | $0.00 |
|---|
| 2020-03-31 | Reported | -$10.86M | (m) | (m) | (m) | -316.80% | $1.40M | -$12.06M | (m) | $12.12M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$11.42M | (m) | (m) | (m) | -623.13% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$11.86M | (m) | $950.00K | (m) | (m) | (m) | (m) | $11.31M | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$341.09M | (m) | (m) | (m) | -869.87% | $1.45M | -$232.89M | (m) | $316.57M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$254.26M | (m) | (m) | (m) | -540.16% | $12.84M | -$194.50M | (m) | $240.25M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$161.97M | (m) | (m) | (m) | -206.08% | $34.48M | -$102.83M | (m) | $189.08M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$158.28M | (m) | (m) | (m) | -338.02% | $2.84M | -$153.09M | (m) | $164.25M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$98.13M | (m) | (m) | (m) | -134.74% | $1.60M | -$128.95M | (m) | $137.02M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | -$44.54M | (m) | (m) | (m) | -130.87% | $9.10M | $88.13M | (m) | $62.10M | (m) | $0.00 |
|---|
| 2019-12-31 | Reported | -$41.38M | (m) | (m) | (m) | -1410.36% | $532.00K | $17.91M | (m) | $37.16M | (m) | $0.00 |
|---|